Pharmaceutical study on Thromboembolism – Pipeline Review, H2 2017. Thromboembolism – Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Thromboembolism (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Thromboembolism pipeline guide also reviews of key players involved in therapeutic development for Thromboembolism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase II, Phase I, IND/CTA Filed and Preclinical stages are 4, 2, 1, 1 and 4 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 4 molecules, respectively.
Purchase This Thromboembolism Pipeline Review H2 2017 Report of 95 Pages with Company profiles and Drugs Analysis at http://www.reportsnreports.com/purchase.aspx?name=1125802
Thromboembolism – Companies Involved in Therapeutics Development
Bayer AG, China Biologic Products Inc, Daiichi Sankyo Company Ltd, F. Hoffmann-La Roche Ltd, Gamma Therapeutics Inc, GlycoMimetics Inc, Green Cross Corp, Ionis Pharmaceuticals Inc, Portola Pharmaceuticals Inc, Verseon Corp
Thromboembolism – Drug Profiles : antithrombin III (human), betrixaban, C-3, edoxaban tosylate, Gammarin, GCC-2107, GMI-1271, IONIS-FXIRx, Lysimab, Recombinant Protein for Thromboembolism, rivaroxaban, TAP-ANV, TRX-1, YG-001
Get Discount on this Research Report at http://www.reportsnreports.com/contacts/discount.aspx?name=1125802
– The pipeline guide provides a snapshot of the global therapeutic landscape of Thromboembolism (Cardiovascular).
– The pipeline guide reviews pipeline therapeutics for Thromboembolism (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Thromboembolism (Cardiovascular) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Thromboembolism (Cardiovascular) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Thromboembolism (Cardiovascular)
List of Figures
Number of Products under Development for Thromboembolism, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products by Targets, H2 2017
Number of Products by Stage and Targets, H2 2017
Number of Products by Mechanism of Actions, H2 2017
Number of Products by Stage and Mechanism of Actions, H2 2017
Number of Products by Routes of Administration, H2 2017
Number of Products by Stage and Routes of Administration, H2 2017
Number of Products by Molecule Types, H2 2017
Number of Products by Stage and Molecule Types, H2 2017
ReportsnReports.com is single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help in purchase decision by mapping your information needs with our huge collection of reports.